The National Centre for Pharmacoeconomics conducts the health technology assessment (HTA) of pharmaceutical products for the Health Service Executive (HSE) in Ireland in collaboration with the HSE Corporate Pharmaceutical Unit (HSE-CPU). The aim of the centre is to promote expertise in Ireland for the advancement of the discipline of pharmacoeconomics through practice, research and education.
Join Suzette Matthijsse, Senior Director, EU Head of Modelling, as she presents during the event.
Plenary Session, October 10, 2024 – 12:10-13:00
Challenges in HTA: The perspective of an international HTA consultancy
Lumanity will be in attendance. Schedule time to meet with our attending staff by reaching out to contact@lumanity.com.
Meet with Our Experts
Suzette Matthijsse
Senior Director, EU Head of Modelling & Analytics
Linda Murphy
Senior Director, Value Demonstration & Early Value and HEOR Strategy Lead
Colin Burke
Senior Health Economist
Daniel Ladino
Senior Health Economist
Barra Patterson
Health Economist